Skip to main content
Signal8
Fallon John A. profile photo

John A. Fallon

CIK: 0001560152

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)2 (50.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COLLEGIUM PHARMACEUTICAL, INC logo
COLL

COLLEGIUM PHARMACEUTICAL, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • COLLEGIUM PHARMACEUTICAL, INC logo
    COLL

    COLLEGIUM PHARMACEUTICAL, INC

    Nov 12, 2025
    Exercise(M)
    Direct
    15K shares at avg. $16.49$247K
  • COLLEGIUM PHARMACEUTICAL, INC logo
    COLL

    COLLEGIUM PHARMACEUTICAL, INC

    Nov 12, 2025
    Exercise(M)
    Direct
    19.9K shares at avg. $9.33$185K
  • COLLEGIUM PHARMACEUTICAL, INC logo
    COLL

    COLLEGIUM PHARMACEUTICAL, INC

    Nov 12, 2025
    Sale(S)
    Direct
    34.9K shares at avg. $47.21$1.6M
  • COLLEGIUM PHARMACEUTICAL, INC logo
    COLL

    COLLEGIUM PHARMACEUTICAL, INC

    May 15, 2025
    Award(A)
    Direct
    9.8K shares-

1-4 of 4

About Fallon John A.

Fallon John A. (SEC CIK 0001560152) files insider reports with the SEC as Director of COLLEGIUM PHARMACEUTICAL, INC (COLL).

Signal8 holds 2 ownership filings by Fallon John A., all Form 4s, filed between May 19, 2025 and Nov 14, 2025. Those filings report 4 transactions, from May 15, 2025 to Nov 12, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Fallon John A.'s filings is in STOUGHTON, MA.

Recent filings by Fallon John A.

  • Nov 12, 2025: Option exercises of COLL shares (2 lines, Form 4, code M).
  • Nov 12, 2025: Open-market sale of COLL shares (Form 4, code S).
  • May 15, 2025: Grant or award of COLL shares (Form 4, code A).

Other insiders filing for COLLEGIUM PHARMACEUTICAL, INC (COLL)

How to read Form 4 transaction codes